Ventas, Inc. (VTR) is scheduled to report third-quarter 2024 results on Oct. 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 80 cents, beating the Zacks Consensus Estimate by 1.3%. The quarterly r ...

Core Viewpoint - The article compares two dividend-paying REITs, Ventas and W.P. Carey, highlighting that W.P. Carey is currently the better investment option due to its reliable dividend growth and diversified portfolio, while Ventas has struggled with dividend cuts and has not yet restored its dividend [2][10]. Company Analysis Ventas - Ventas is a healthcare REIT that owns senior housing assets, medical offices, and research facilities, and has a significant portion of its portfolio in senior housing operating assets (SHOPs) [3][4]. - The company faced financial difficulties during the COVID-19 pandemic, leading to a dividend cut due to decreased cash flow from its SHOP portfolio [4][6]. - Although Ventas reported a 7% year-over-year increase in funds from operations (FFO) in Q2 2024, it has not yet resumed dividend payments, raising concerns about its focus on providing reliable income to investors [5][6]. W.P. Carey - W.P. Carey is a net lease REIT that offers a higher dividend yield of 5.6%, compared to Ventas' 2.8% yield, and is known for its diversified portfolio across various sectors including warehouse, industrial, and retail [7][8]. - The company recently exited the office asset segment, which constituted 16% of its portfolio, resulting in a dividend reset; however, it has since resumed increasing its dividend every quarter, signaling a commitment to returning value to shareholders [8][9]. - W.P. Carey is recognized for its management's focus on maintaining and growing dividends, making it a more attractive option for dividend investors compared to Ventas [9][10].

Shares of Ventas (VTR) have gained 48.9% in the past six months compared with the industry's growth of 15.8%. This healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to gain from favor ...

Ventas (VTR) secured an agreement ("2024 Kindred Agreements") with Kindred Healthcare, LLC and its parent company, ScionHealth. This agreement is regarding 23 long-term acute care hospitals ("LTACs") whose lease term is scheduled to mature on April 30, 2025, under the existing master lease between Ventas and Kindred. This move enhances patient care facilities, strengthens the existing master lease and provide upside for Ventas. The company also obtains rights to additional revenue-sharing rent and warrants. ...

Ventas' (VTR) senior housing operating portfolio (SHOP) is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. Its outpatient medical and research portfolio is expected to gain from the favorable outpatient visit trends and the rising need for research related to life-saving vaccines and therapeutics. A healthy balance sheet position is likely to support its growth endeavors. However, dependence on few tenants and high interest rates add to its concern. Las ...

Core Viewpoint - Ventas has significantly outperformed the Vanguard Real Estate ETF in 2024, achieving a total return of approximately 22% compared to the ETF's 10% gain, but its elevated valuation suggests a Hold rating is appropriate [2][14] Company Overview - Ventas is a healthcare REIT with 41% of its net operating income (NOI) derived from the Senior Housing Operating Portfolio (SHOP), 31% from the Outpatient Medical & Research Portfolio (OM&R), and 28% from Triple-Net Properties [3] - The company operates a total of 1,345 properties with a gross book value of $32.067 billion and an annual NOI of $2.083 billion [3] Operational Overview - In Q2 2024, Ventas reported a normalized FFO of $0.80 per share, reflecting a 7% year-over-year increase, driven by a 15.2% increase in same-store cash NOI in the SHOP portfolio [4] - The overall same-store cash NOI growth for the company was 7.8%, with modest increases in OM&R and Triple-Net portfolios at 3.3% and 2.6% respectively [4] Increased 2024 Guidance - Following strong Q2 performance, Ventas raised its full-year normalized FFO guidance to approximately $3.15 per share, representing a 5% year-over-year increase [5][6] Capital Structure - As of Q2 2024, Ventas had a net debt of $12.9 billion, with a market capitalization of $24.7 billion, resulting in net debt accounting for 34% of the enterprise value [7] - The weighted average interest rate on the company's debt is 4.3%, with only 9% of the debt at floating rates, limiting benefits from potential monetary policy easing [8] Market-Implied Cap Rate - The market-implied cap rate is approximately 5%, indicating that the strong NOI growth is already reflected in the company's valuation [9] General and Administrative Expenses - The company anticipates general and administrative expenses of about $158 million in 2024, which is relatively low compared to peers, suggesting efficient management [10] Prospects and Valuation - While robust NOI growth is expected to continue, it is anticipated to moderate to low-to-mid single digits due to occupancy limits in the SHOP portfolio [11] - The elevated normalized FFO multiple and limited near-term benefits from Fed rate cuts lead to a Hold rating for Ventas shares [11][14] Covered Call Strategy - To enhance returns, the company suggests a covered call strategy for investors holding Ventas shares, which could provide additional income and mitigate risks during market downturns [12][14]

Shares of Ventas (VTR) have gained 34.1% in the past six months compared with the industry's growth of 7.9%. This Chicago-based healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to ga ...

Ventas, Inc. (VTR) reported second-quarter 2024 normalized funds from operations (FFO) per share of 80 cents, which surpassed the Zacks Consensus Estimate of 79 cents. The reported figure increased 6.7% from the prior-year quarter's tally. Results reflect growth in occupancy in the SHOP same-store portfolio contributing to higher revenue generation. The company has improved its 2024 outlook. VTR clocked in revenues of $1.20 billion in the second quarter, which beat the Zacks Consensus Estimate of $1.19 bill ...

Core Insights - Ventas reported revenue of $1.2 billion for the quarter ended June 2024, reflecting an 8.6% increase year-over-year and surpassing the Zacks Consensus Estimate of $1.19 billion by 0.78% [1] - The company's EPS was $0.80, significantly higher than $0.26 in the same quarter last year, and exceeded the consensus estimate of $0.79 by 1.27% [1] Revenue Breakdown - Rental income from Triple-net leased properties was $153.93 million, slightly above the average estimate of $153.42 million, showing a year-over-year decrease of 0.3% [3] - Rental income from the outpatient medical & research portfolio was $218.85 million, slightly below the average estimate of $219.42 million [4] - Total rental income was reported at $372.79 million, close to the average estimate of $372.84 million, with a year-over-year increase of 0.7% [5] - Resident fees and services generated $817.60 million, exceeding the average estimate of $815.27 million, marking a significant year-over-year increase of 12.8% [6] - Third-party capital management revenues were $4.33 million, below the average estimate of $4.48 million [7] - Income from loans and investments was $1.44 million, lower than the average estimate of $1.67 million, representing a substantial year-over-year decline of 78.1% [8] - Interest and other income reached $4.83 million, below the average estimate of $5.43 million, but showed a remarkable year-over-year increase of 367.5% [9] Net Operating Income (NOI) - NOI from Triple-Net Leased Properties was $150.43 million, slightly below the average estimate of $150.53 million [9] - NOI from SHOP was reported at $214.24 million, exceeding the average estimate of $210.47 million [10] - NOI from the Office Outpatient medical & research portfolio was $146.27 million, above the average estimate of $144.53 million [11] Stock Performance - Ventas shares have returned 5.1% over the past month, outperforming the Zacks S&P 500 composite's return of 1.1% [11] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [11]

分组1 - Ventas reported quarterly funds from operations (FFO) of $0.80 per share, exceeding the Zacks Consensus Estimate of $0.79 per share, and up from $0.75 per share a year ago, representing an FFO surprise of 1.27% [1] - The company posted revenues of $1.2 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.78%, compared to $1.11 billion in the same quarter last year [2] - Over the last four quarters, Ventas has surpassed consensus FFO estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock's immediate price movement will depend on management's commentary on the earnings call and future FFO expectations [3] - Ventas shares have increased by approximately 9.2% since the beginning of the year, while the S&P 500 has gained 15.8% [3] - The current consensus FFO estimate for the coming quarter is $0.80 on $1.21 billion in revenues, and for the current fiscal year, it is $3.16 on $4.82 billion in revenues [7] 分组3 - The Zacks Industry Rank indicates that the REIT and Equity Trust - Other industry is currently in the top 39% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Ventas is currently mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]